Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) Financings

Aspire Biopharma Holdings, Inc.

Financings

RaiseDate
Private placement of series A Convertible Preferred Stock
Closed: US$21M raised · RBW Capital Partners LLC
Dealers: RBW Capital Partners LLC (lead)
Use of proceeds: Working capital, a portion of the cash component of the proposed DCS acquisition, and general corporate purposes
Apr 20, 2026
Senior secured convertible debenture
Announced: US$3M · Dawson James Securities, Inc. +1
Dealers: Dawson James Securities, Inc. (co-lead), RBW Capital Partners LLC (co-lead)
Use of proceeds: General working capital and operating expenses
Feb 20, 2025
Business combination proceeds (SPAC trust funds and concurrent PIPE)
Closed: US$3.8M raised
Use of proceeds: Accelerate development of its pipeline and finance key therapeutic programs to data announcements
Feb 20, 2025

Read by 6ix AI from the company's releases